+7 (495) 414-60-88

Moscow, 3rd Cherepkovskaya str. 15A

Location map



AZT Pharma K.B.

Is the only Russian manufacturer and developer of domestic anti-retroviral drugs.

News of the Russian pharmaceutical industry

Утвержден регламент по предоставлению госуслуги регистрации лекарственных препаратов
25 January, 2017
Изменение порядка госзакупок лекарств поддержано Комитетом Госдумы
19 January, 2017
Минюст зарегистрировал Правила надлежащей практики хранения и перевозки ЛП
11 January, 2017
Разработаны правила функционирования информационно-аналитической системы мониторинга и контроля в сфере госзакупок лекарств Подробнее читайте: http://www.pharmvestnik.ru/publs/lenta/v-rossii/razrabotany-pravila-funktsionirovanija-informatsionno-anali
09 January, 2017
Изменения в 61-ФЗ, подготовленные Минпромторгом
22 December, 2016


» Архив новостей
About us

Enterprise «AZT PHARMA K.B.», manufacturing antiviral drugs traces its history back to 1992, when our country began vigorously and rapidly to change under the impact of time.

In those years, a group of scientists, headed by Academician of RAS Alexander Antonovich Kraevskiy, was invented by a unique drug Phosphazid belonging to the class of reverse transcriptase inhibitors intended for the treatment and prevention of human immunodeficiency virus (HIV). After the conducted clinical research and development of industrial technology, the drug received the trade name Nikavir® and the first registration certificate, dated 1999. For its production and was organized by the above company.

At the end of the XX beginning of the XXI century in the line of the company were drugs such as Acyclovir AZT and Terbinafine. At the same time was first registered drug Nikavir (Phosphazid). At about this time, the company set a course for production and development of new drugs against HIV. Currently, the main drug remains Никавир, and in development is the original drugs.

At the present time LLC «AZT PHARMA K.B.» is based on the squares FSBO Russian Cardiological Research and Production Complex, under the patronage of his unchanging Director Evgeny Ivanovich Chazov, who in those distant years unmistakably been discussed potential developed a unique product for the treatment and prevention of HIV.

google_analitics